News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,964 Results
Type
Article (42256)
Company Profile (278)
Press Release (684416)
Multimedia
Podcasts (140)
Webinars (26)
Section
Business (205885)
Career Advice (2103)
Deals (35680)
Drug Delivery (118)
Drug Development (81602)
Employer Resources (193)
FDA (16473)
Job Trends (15034)
News (348104)
Policy (32832)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2634)
Accelerated approval (31)
Adcomms (24)
Allergies (139)
Alliances (49988)
ALS (169)
Alzheimer's disease (1681)
Antibody-drug conjugate (ADC) (310)
Approvals (16735)
Artificial intelligence (550)
Autoimmune disease (151)
Automation (37)
Bankruptcy (363)
Best Places to Work (11707)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (183)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (640)
Cancer (4810)
Cardiovascular disease (396)
Career advice (1779)
Career pathing (38)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (744)
Cervical cancer (36)
Clinical research (69679)
Collaboration (1729)
Company closure (4)
Compensation (1152)
Complete response letters (53)
COVID-19 (2727)
CRISPR (89)
C-suite (843)
Cystic fibrosis (146)
Data (6223)
Decentralized trials (2)
Denatured (73)
Depression (132)
Diabetes (500)
Diagnostics (6781)
Digital health (46)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (259)
Drug pricing (187)
Drug shortages (29)
Duchenne muscular dystrophy (229)
Earnings (90296)
Editorial (56)
Employer branding (24)
Employer resources (163)
Events (118117)
Executive appointments (984)
FDA (19584)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1469)
Gene editing (195)
Generative AI (46)
Gene therapy (603)
GLP-1 (969)
Government (4675)
Grass and pollen (6)
Guidances (384)
Healthcare (19051)
HIV (57)
Huntington's disease (45)
IgA nephropathy (81)
Immunology and inflammation (247)
Immuno-oncology (57)
Indications (104)
Infectious disease (2987)
Inflammatory bowel disease (189)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (242)
Interviews (335)
IPO (16703)
IRA (52)
Job creations (3654)
Job search strategy (1478)
JPM (62)
Kidney cancer (15)
Labor market (94)
Layoffs (551)
Leadership (37)
Legal (7960)
Liver cancer (92)
Longevity (15)
Lung cancer (651)
Lymphoma (375)
Machine learning (43)
Management (62)
Manufacturing (785)
MASH (163)
Medical device (13874)
Medtech (13927)
Mergers & acquisitions (20041)
Metabolic disorders (1268)
Multiple sclerosis (162)
NASH (16)
Neurodegenerative disease (313)
Neuropsychiatric disorders (87)
Neuroscience (2909)
Neurotech (1)
NextGen: Class of 2026 (6596)
Non-profit (4560)
Now hiring (66)
Obesity (594)
Opinion (268)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (223)
Parkinson's disease (280)
Partnered (33)
Patents (490)
Patient recruitment (481)
Peanut (55)
People (59356)
Pharmaceutical (64)
Pharmacy benefit managers (29)
Phase 1 (21723)
Phase 2 (30666)
Phase 3 (22835)
Pipeline (5186)
Policy (289)
Postmarket research (2572)
Preclinical (9219)
Press Release (66)
Prostate cancer (236)
Psychedelics (47)
Radiopharmaceuticals (280)
Rare diseases (833)
Real estate (5969)
Recruiting (75)
Regulatory (24540)
Reports (67)
Research institute (2447)
Resumes & cover letters (359)
Rett syndrome (27)
RNA editing (19)
RSV (76)
Schizophrenia (146)
Series A (241)
Series B (192)
Service/supplier (11)
Sickle cell disease (96)
Special edition (24)
Spinal muscular atrophy (157)
Sponsored (44)
Startups (3647)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (65)
Vaccines (994)
Venture capital (90)
Weight loss (381)
Women's health (94)
Worklife (21)
Date
Today (138)
Last 7 days (628)
Last 30 days (2212)
Last 365 days (30244)
2026 (3093)
2025 (30573)
2024 (35543)
2023 (40381)
2022 (51455)
2021 (56039)
2020 (54459)
2019 (47023)
2018 (35358)
2017 (32381)
2016 (31749)
2015 (37814)
2014 (31531)
2013 (26605)
2012 (28821)
2011 (29464)
2010 (27522)
Location
Africa (746)
Alabama (84)
Alaska (7)
Arizona (308)
Arkansas (14)
Asia (39485)
Australia (6467)
California (11258)
Canada (3275)
China (1100)
Colorado (476)
Connecticut (480)
Delaware (334)
Europe (85708)
Florida (1672)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (860)
India (64)
Indiana (521)
Iowa (22)
Japan (425)
Kansas (125)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1386)
Massachusetts (8082)
Michigan (320)
Minnesota (625)
Mississippi (5)
Missouri (127)
Montana (32)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2988)
New Mexico (28)
New York (2979)
North Carolina (1481)
North Dakota (8)
Northern California (5476)
Ohio (335)
Oklahoma (21)
Oregon (44)
Pennsylvania (2272)
Puerto Rico (23)
Rhode Island (47)
South America (1116)
South Carolina (65)
South Dakota (1)
Southern California (4391)
Tennessee (173)
Texas (1747)
United States (39985)
Utah (339)
Vermont (1)
Virginia (262)
Washington D.C. (81)
Washington State (920)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
726,964 Results for "magnetic insight inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH EVOTEC
Strategic Drug Development in a Funding Crisis: Expert Insights on Risk Profiling, Efficiency, and Innovation
The market outlook is full of uncertainty and pitfalls. Experts weigh in on how to mitigate risks.
October 13, 2025
·
8 min read
·
BioSpace Insights
IN PARTNERSHIP WITH ELEMENT
Innovation, Resilience, and the Future of Global Manufacturing
In this episode presented by Element Materials Technology, BioSpace’s head of insights discusses how China, historically focused on manufacturing, is increasingly becoming an innovation leader, particularly in pharmaceuticals, with guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney. Ultimately, balanced strategies involve domestic capacity investments coupled with global collaboration.
October 30, 2025
·
1 min read
·
BioSpace Insights
IN PARTNERSHIP WITH PII
Thoughtful Tech: How Removing Technological Burdens Can Improve Clinical Trial Compliance and Patient Experience
In this episode presented by PII, BioSpace’s head of insights discusses how to relieve clinical trial patients of technological burden to improve compliance with guests Oliver Eden and Travis Webb.
November 6, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
October 29, 2025
·
9 min read
IN PARTNERSHIP WITH ECLIPSEBIO
Webinar: The Future of mRNA Medicine: How Advanced Data Empowers Cures
This discussion focuses on how sequencing-based insights can power AI-driven design and data-driven validation, helping to develop safe and effective drugs for treating and preventing disease.
October 22, 2025
·
1 min read
·
BioSpace Insights
Press Releases
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
February 5, 2026
·
4 min read
IN PARTNERSHIP WITH PII
Work Smart, Build Trust: Connecting Technology, Patient Compliance and Data Processing
In this episode presented by PII, BioSpace’s head of insights discusses decentralized clinical studies and how connected technology can improve patient compliance with guests Oliver Eden and Travis Webb.
October 16, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
January 8, 2026
·
6 min read
Press Releases
Aminoglycosides Market Size to worth US$ 3.09 Billion by 2033, Coherent Market Insights
January 20, 2026
·
1 min read
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.
January 16, 2025
·
1 min read
·
Lori Ellis
1 of 72,697
Next
